3/14/2025Fosun Pharma to Divest United Family Healthcare for $124.1M

3/14/2025Pyrotech’s PTT-936 Gains Approval for Clinical Trials in China for Ad...

3/14/2025BioCity Announces Clinical Collaboration to Evaluate BC3195 in Combo w...

3/14/2025Roche's Itovebi (Inavolisib) Wins Approval in China for Advanced Breas...

3/13/2025Insilico Medicine Secures $110M, Explores IPO Amid AI Drug Discovery B...

3/13/2025China Issues Guidelines for Informatization of County-Level Healthcare...

3/13/2025AskBio Receives FDA Regenerative Medicine Advanced Therapy designation...

3/12/2025NewDEL Biotech Completes Series A+ Financing Led by XtalPi to Accelera...

3/12/2025Novartis' Cosentyx Receives Fifth Indication Approval in China for Hid...

3/12/2025Harbour BioMed Launches Élancé Therapeutics to Advance Next-Generati...

3/12/2025CDE Publicizes the List of Reference Formulations for GQCE Studies (91...

More>>

3/10/2025China Biopharma Tracker – February 2025 (PharmaDJ)

3/10/2025The Bright Future Amidst Challenges: An Outlook on China's Pharma Econ...

3/6/2025AI, Biomanufacturing, and Six Takeaways from China’s Government Work ...

3/4/2025Trump's 'America First' Investment Policy Raises Uncertainty for US-Ch...

2/28/2025Pace, Price of China Licensing Deals Continues to Rise (BioCentury)

2/28/2025China's Tech Giants Look to Healthcare (The Wire China)

2/27/2025Fail to Launch: Affordable Gene Therapy from China - A Realty Within R...

2/26/2025Chinese Biotech Firms Cash in on Promising Drug Discoveries via Licens...

2/21/2025Lessons from China's 2024 National Negotiation of Drug Prices (GT)

2/19/2025It's Not Just AI. China's Medicines Are Surprising the World, Too (Eco...

2/18/2025China Performance of Leading MNCs Fell in H2/2024: A Turning Point?

More>>